22nd Century Group Company Profile (NYSE:XXII)

Analyst Ratings

Consensus Ratings for 22nd Century Group (NYSE:XXII) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for 22nd Century Group (NYSE:XXII)
Show:
DateFirmActionRatingPrice TargetActions
2/22/2016Chardan CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for 22nd Century Group (NYSE:XXII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/9/2016Q1($0.03)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3($0.03)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.02)($0.02)$1.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2015($0.03)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/14/2014Q314($0.03)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014($0.03)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014($0.03)($0.09)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q4($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for 22nd Century Group (NYSE:XXII)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for 22nd Century Group (NYSE:XXII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for 22nd Century Group (NYSE:XXII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/29/2016John T BrodfuehrerCFOBuy12,500$0.77$9,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Michael Robert MoynihanVPSell50,000$1.40$70,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2015Joseph PandolfinoDirectorSell91,178$0.95$86,619.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2014Joseph PandolfinoDirectorSell105,124$1.65$173,454.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Joseph PandolfinoDirectorSell41,722$1.54$64,251.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Joseph PandolfinoDirectorSell52,683$1.60$84,292.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014Joseph PandolfinoDirectorSell75,768$1.62$122,744.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Joseph PandolfinoDirectorSell67,836$1.65$111,929.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Richard M SandersDirectorBuy20,000$2.23$44,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2014Michael Robert MoynihanVPSell100,000$2.44$244,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Joseph PandolfinoCEOSell95,000$5.73$544,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.55$15,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Clearwater Partners, LlcMajor ShareholderSell10,000$1.35$13,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2013Clearwater Partners, LlcMajor ShareholderSell30,074$1.09$32,780.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Clearwater Partners, LlcMajor ShareholderSell11,826$0.98$11,589.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013Clearwater Partners, LlcMajor ShareholderSell7,100$1.03$7,313.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2013Clearwater Partners, LlcMajor ShareholderSell9,000$1.15$10,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for 22nd Century Group (NYSE:XXII)
DateHeadline
07/22/16 07:10 PM22nd Century Group Inc (AMEX:XXII) Realized Volatility Hits An Elevated Level - CML News
07/20/16 11:58 AMETF’s with exposure to 22nd Century Group, Inc. : July 20, 2016 -
07/19/16 08:20 AM22nd Century Group Incorporated (NYSEMKT:XXII) Shorted Shares Increased 5.99% After Market Selling - Consumer Eagle
07/15/16 12:45 PM22nd Century : World Health Organization Recommends “Mandated Reductions in Nicotine to Minimally Addictive Levels”
07/14/16 11:00 AMNicotine Reduction Strategy is Championed by Growing Number of Scientists and Public Health Experts - Business Wire (press release)
07/14/16 07:45 AMNicotine Reduction Strategy is Championed by Growing Number of Scientists and Public Health Experts - [Business Wire] - 22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that in this month’s issue of Tobacco Control, Drs.
07/12/16 07:38 PMWorld Health Organization Recommends “Mandated Reductions in Nicotine to Minimally Addictive Levels” - Business Wire (press release)
07/11/16 12:43 PM22nd Century’s Very Low Nicotine Cigarettes Reduce Smoking and Are Now Associated with Reduced Alcohol Use - [at noodls] - New study suggests that 22nd Century's Proprietary Very Low Nicotine cigarettes may actually have two positive effects on public health. ... This is an abstract of the original noodl. To continue reading ...
07/11/16 12:15 PMWorld Health Organization Recommends “Mandated Reductions in Nicotine to Minimally Addictive Levels” - [Business Wire] - 22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that the World Health Organization Study
07/09/16 10:16 AM22nd Century Group Incorporated (NYSEMKT:XXII) Shorted Shares Increased 5.99% After Market Selling - Engelwood Daily
07/03/16 04:28 AM22nd Century Group Incorporated (NYSEMKT:XXII) Short Interest Increased By 5.99% - Engelwood Daily
06/29/16 07:18 PM22nd Century Group Incorporated (NYSEMKT:XXII) Short Interest Increased By 5.99% - Press Telegraph
06/28/16 07:21 PM22nd Century's Very Low Nicotine Cigarettes Reduce Smoking and Are Now Associated with Reduced Alcohol Use - Business Wire (press release)
06/22/16 07:21 PMNew Study Shows Cigarettes Containing 22nd Century’s Proprietary Tobacco Reduce Smoking and Toxicant Exposure
06/22/16 07:21 PM22nd Century Group XXII
06/20/16 04:22 PMWhich Stocks To Watch Ahead Of The Potential Us-Wide Federal Legalization Of Medical Cannabis -
06/18/16 04:41 AM22nd Century Group Inc. (NYSEMKT:XXII)'s SPECTRUM Cigarettes Get CDC Nod - Scibility Media
06/18/16 04:41 AM22nd Century Group Inc (XXII) Jumps 6.93% on June 16 - Equities.com
06/16/16 07:34 PMLow nicotine cigarettes could help reduce smoking harm
06/16/16 07:34 PM22nd Century's Proprietary SPECTRUM® Cigarettes Identified as Crucial Tool in Human Addiction Studies
06/16/16 09:02 AM10:02 am 22nd Century Group announces scientists with The Centers for Disease Control and Prevention published a detailed characterization of SPECTRUM -
06/16/16 08:44 AM22nd Century’s Proprietary SPECTRUM® Cigarettes Identified as Crucial Tool in Human Addiction Studies - [Business Wire] - 22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that scientists with The Centers for Disease Control and Prevention published a detailed characterization of the Company’s SPECTRUM® Variable Nicotine Research Cigarettes, calling 22nd Century’s proprietary cigarettes an “important tool in clinical studies for investigating… the impact ...
06/14/16 06:56 PM22nd Century : Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals
06/01/16 08:11 PM22nd Century Group Inc (XXII) Drops 7.99% on June 01 - Equities.com - 22nd Century Group Inc (XXII) Drops 7.99% on June 01Equities.com22nd Century Group Inc (XXII) was one of the Russell 2000's biggest losers for Wednesday June 01 as the stock slid 7.99% to $0.84, a loss of $-0.073 per share. Starting at an opening price of $0.92 a share, the stock traded between $0.84 and $0.94 over ...and more »
05/31/16 07:51 PM22nd Century Group Inc (XXII) Jumps 6.41% on May 31 - Equities.com - 22nd Century Group Inc (XXII) Jumps 6.41% on May 31Equities.com22nd Century Group Inc (XXII) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 6.41% to $0.91, representing a gain of $0.0551 per share. Some 564,033 shares traded hands on 664 trades, compared with an ...and more »
05/30/16 08:55 PMPerformance at a Glance on 22nd Century Group, Inc. (:XXII) - HNN - Performance at a Glance on 22nd Century Group, Inc. (:XXII)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how 22nd Century Group, Inc. (:XXII)'s stock has performed at various points in its past. Currently, the ...and more »
05/28/16 01:59 PM22nd Century Group, Inc. (NYSEMKT:XXII) Insider Activities Are in the Air - iStreetWire - iStreetWire22nd Century Group, Inc. (NYSEMKT:XXII) Insider Activities Are in the AiriStreetWire22nd Century Group, Inc. (XXII) up 5.38 per cent in the past week, is under coverage of 1 analysts who collectively recommend a hold rating on stock. 1 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 1 equity ...
05/27/16 08:22 AM22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals - [Business Wire] - 22nd Century Group, Inc. , a plant biotechnology company that is a leader in tobacco harm reduction, announced today that on May 26, 2016, Paul J. Rushton, Ph.D., the Company’s Vice President of Plant Biotechnology, gave a seminar to discuss 22nd Century’s novel Very Low Nicotine smoking cessation aid at Hofstra Northwell School of Medicine on the campus of Hofstra University in Hempstead, New York....
05/26/16 02:03 PMHealthcare Stocks within Traders Concentration: Exelixis, Inc. (NASDAQ:EXEL) , 22nd Century Group, Inc (NYSEMKT ... - Is stories - Healthcare Stocks within Traders Concentration: Exelixis, Inc. (NASDAQ:EXEL) , 22nd Century Group, Inc (NYSEMKT ...Is storiesIn most recently trading session on 5/25/2016, 22nd Century Group, Inc (NYSEMKT:XXII) dropped -2.22% while traded on 1.64 million shares versus it's an average volume of 475.89 thousand shares. The company recorded the last trade with the price of ...and more »
05/26/16 02:03 PM22nd Century Group (NYSEMKT:XXII) & Allergan plc Ordinary Shares (NYSE:AGN) Healthcare Stocks Alert - Wall Street 24 - 22nd Century Group (NYSEMKT:XXII) & Allergan plc Ordinary Shares (NYSE:AGN) Healthcare Stocks AlertWall Street 24On Tuesday, Shares of 22nd Century Group Inc (NYSEMKT:XXII) gained 6.01% to $0.900. The share price is trading in a range of $0.86 – $0.95. The stock exchanged hands with 2.57 Million shares contrast to its average daily volume of 476,046 shares.and more »
05/26/16 02:03 PM22nd Century Group Inc (XXII) is Trading Higher on Unusual Volume for May 23 - Equities.com - 22nd Century Group Inc (XXII) is Trading Higher on Unusual Volume for May 23Equities.com22nd Century Group Inc (XXII) experienced unusually high volume on May. 23, as the stock gained 10.17% to a closing price of $0.85. The stock saw 2.08 million shares trade hands over the course of the day on 2,424 trades. Given that the stock's average ...
05/26/16 02:03 PMHealthcare Stocks in the Spotlight: 22nd Century Group Inc (NYSEMKT:XXII), Zimmer Biomet Holdings Inc(NYSE:ZBH) - NYSE Journal (press release) - Healthcare Stocks in the Spotlight: 22nd Century Group Inc (NYSEMKT:XXII), Zimmer Biomet Holdings Inc(NYSE:ZBH)NYSE Journal (press release)On Wednesday, Shares of 22nd Century Group Inc (NYSEMKT:XXII), subtract -2.22% and closed at $0.880 in the last trading session. The last trading range of the stock ranges between $0.86 and $0.98. 22nd Century Group, Inc. (NYSE MKT:XXII), a plant ...and more »
05/26/16 02:03 PM22nd Century Group Inc (XXII) Jumps 6.01% on May 24 - Equities.com - 22nd Century Group Inc (XXII) Jumps 6.01% on May 24Equities.com22nd Century Group Inc (XXII) was among the biggest gainers on the Russell 2000 for Tuesday May 24 as the stock popped 6.01% to $0.90, representing a gain of $0.051 per share. Some 2.57 million shares traded hands on 3,207 trades, compared with an ...and more »

Social

About 22nd Century Group

22nd Century Group logo22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XXII
  • CUSIP:
Key Metrics:
  • Previous Close: $0.81
  • 50 Day Moving Average: $0.8234
  • 200 Day Moving Average: $0.9087
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $61.56M
  • Current Year EPS Consensus Estimate: $-0.1600 EPS
  • Next Year EPS Consensus Estimate: $-0.1400 EPS
Additional Links:
22nd Century Group (NYSE:XXII) Chart for Monday, July, 25, 2016